FDA Sarclisa Approval Marks Sanofi's Reentry Into Oncology

 
• By Jessica Merrill

The anti-CD38 antibody will face an entrenched rival, J&J's Darzalex, for multiple myeloma.

Milestone on Road
Sanofi reached a milestone getting a new cancer drug to market • Source: Shutterstock

More from New Products

More from Scrip